AI eye test could revolutionize diabetes care

NCT ID NCT04624737

Completed Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether artificial intelligence (AI) can help doctors better predict how diabetic retinopathy (an eye disease from diabetes) will progress. Over 3,000 adults with diabetes were followed for about 2 years. The goal was to create a smarter system that uses eye images and patient data to improve treatment decisions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus diabetic retinopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC RETINOPATHY

Contacts and locations

Locations

CHU de NICE HÔPITAL PASTEUR 2

Nice, CS 51069_06001, Nice cedex1, France
Centre Broca / Mutuelle Generale

Paris, 75013, France
Chic Creteil

Créteil, 94010, France
Chu Avicenne

Bobigny, 93000, France
Chu Bordeaux

Bordeaux, 33000, France
Chu Brest

Brest, 29200, France
Chu Dijon

Dijon, 21000, France
Chu Lariboisiere

Paris, 75010, France
Chu Lyon Croix Rousse

Lyon, 69317, France
Chu Pitie Salpetriere

Paris, 75013, France
Clinique Monticelli

Marseille, 13008, France
Clinique ophtalmologique du CHU de Nantes

Nantes, 44000, France
Fondation Rothschild

Paris, 75019, France
Hôpital des 15-20

Paris, 75571, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.